156 related articles for article (PubMed ID: 32758562)
1. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
Lee HJ; Mazzone P; Feller-Kopman D; Yarmus L; Hogarth K; Lofaro LR; Griscom B; Johnson M; Choi Y; Huang J; Bhorade S; Spira A; Kennedy GC; Wahidi MM;
Chest; 2021 Jan; 159(1):401-412. PubMed ID: 32758562
[TBL] [Abstract][Full Text] [Related]
2. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
Sethi S; Oh S; Chen A; Bellinger C; Lofaro L; Johnson M; Huang J; Bhorade SM; Bulman W; Kennedy GC
BMC Pulm Med; 2022 Jan; 22(1):26. PubMed ID: 34991528
[TBL] [Abstract][Full Text] [Related]
3. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
[TBL] [Abstract][Full Text] [Related]
4. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
[TBL] [Abstract][Full Text] [Related]
5. Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
Raval AA; Benn BS; Benzaquen S; Maouelainin N; Johnson M; Huang J; Lofaro LR; Ansari A; Geurink C; Kennedy GC; Bulman WA; Kurman JS
Respir Med; 2022; 204():106990. PubMed ID: 36283245
[TBL] [Abstract][Full Text] [Related]
6. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
Mazzone P; Dotson T; Wahidi MM; Bernstein M; Lee HJ; Feller Kopman D; Yarmus L; Whitney D; Stevenson C; Qu J; Johnson M; Walsh PS; Huang J; Lofaro LR; Bhorade SM; Kennedy GC; Spira A; Rivera MP; ;
PLoS One; 2022; 17(7):e0268567. PubMed ID: 35830375
[TBL] [Abstract][Full Text] [Related]
7. Comparing modalities for risk assessment in patients with pulmonary lesions and nondiagnostic bronchoscopy for suspected lung cancer.
Yu DH; Shafiq M; Batra H; Johnson M; Griscom B; Chamberlin J; Lofaro LR; Huang J; Bulman WA; Kennedy GC; Yarmus LB; Lee HJ; Feller-Kopman D
BMC Pulm Med; 2022 Nov; 22(1):442. PubMed ID: 36434574
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules.
Vachani A; Hammoud Z; Springmeyer S; Cohen N; Nguyen D; Williamson C; Starnes S; Hunsucker S; Law S; Li XJ; Porter A; Kearney P
Lung; 2015 Dec; 193(6):1023-7. PubMed ID: 26376647
[TBL] [Abstract][Full Text] [Related]
10. Analytical performance of a bronchial genomic classifier.
Hu Z; Whitney D; Anderson JR; Cao M; Ho C; Choi Y; Huang J; Frink R; Smith KP; Monroe R; Kennedy GC; Walsh PS
BMC Cancer; 2016 Feb; 16():161. PubMed ID: 26920854
[TBL] [Abstract][Full Text] [Related]
11. Managing solitary pulmonary nodules.
Jain P; Kathawalla SA; Arroliga AC
Cleve Clin J Med; 1998 Jun; 65(6):315-26. PubMed ID: 9637959
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
[TBL] [Abstract][Full Text] [Related]
13. [Subcentimeter pulmonary nodule: diagnostic and therapeutic problems].
Kowalewski J
Pol Merkur Lekarski; 2008 Oct; 25(148):368-73. PubMed ID: 19145939
[TBL] [Abstract][Full Text] [Related]
14. Factors that influence physician decision making for indeterminate pulmonary nodules.
Vachani A; Tanner NT; Aggarwal J; Mathews C; Kearney P; Fang KC; Silvestri G; Diette GB
Ann Am Thorac Soc; 2014 Dec; 11(10):1586-91. PubMed ID: 25386795
[TBL] [Abstract][Full Text] [Related]
15. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
[TBL] [Abstract][Full Text] [Related]
16. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of solitary and multiple pulmonary nodules.
Viggiano RW; Swensen SJ; Rosenow EC
Clin Chest Med; 1992 Mar; 13(1):83-95. PubMed ID: 1582151
[TBL] [Abstract][Full Text] [Related]
18. Lung Nodule Management: An Interventional Pulmonology Perspective.
Chaddha U; Kurman JS; Mahajan A; Hogarth DK
Semin Respir Crit Care Med; 2018 Dec; 39(6):661-666. PubMed ID: 30641583
[TBL] [Abstract][Full Text] [Related]
19. Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm.
Chhajed PN; Bernasconi M; Gambazzi F; Bubendorf L; Rasch H; Kneifel S; Tamm M
Chest; 2005 Nov; 128(5):3558-64. PubMed ID: 16306037
[TBL] [Abstract][Full Text] [Related]
20. Flexible fiberoptic bronchoscopy and fluoroscopically guided transbronchial biopsy in the management of solitary pulmonary nodules.
Fletcher EC; Levin DC
West J Med; 1982 Jun; 136(6):477-83. PubMed ID: 7113195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
